InvestorsHub Logo
Post# of 251718
Next 10
Followers 97
Posts 92809
Boards Moderated 4
Alias Born 10/29/2007

Re: None

Thursday, 03/27/2014 8:26:40 AM

Thursday, March 27, 2014 8:26:40 AM

Post# of 251718
Ad comm meeting approaches for Durata drug
Anti-Infective Drugs Advisory Committee meets on Monday to review Durata Therapeutics' (DRTX) antibacterial Dalvance (dalbavancin) NDA.
PDUFA date is May 26.
Consensus total revenue estimates for 2014 and 2015 are $16.3M and $67.2M, respectively.
briefing docs..http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm385739.htm

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.